209 related articles for article (PubMed ID: 26169971)
1. Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor.
Karpathakis A; Dibra H; Pipinikas C; Feber A; Morris T; Francis J; Oukrif D; Mandair D; Pericleous M; Mohmaduvesh M; Serra S; Ogunbiyi O; Novelli M; Luong T; Asa SL; Kulke M; Toumpanakis C; Meyer T; Caplin M; Meyerson M; Beck S; Thirlwell C
Clin Cancer Res; 2016 Jan; 22(1):250-8. PubMed ID: 26169971
[TBL] [Abstract][Full Text] [Related]
2. SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.
Hofving T; Elias E; Rehammar A; Inge L; Altiparmak G; Persson M; Kristiansson E; Johansson ME; Nilsson O; Arvidsson Y
BMC Cancer; 2021 Jan; 21(1):101. PubMed ID: 33509126
[TBL] [Abstract][Full Text] [Related]
3. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
[TBL] [Abstract][Full Text] [Related]
4. Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect?
Delgado Verdugo A; Crona J; Maharjan R; Hellman P; Westin G; Björklund P
Horm Metab Res; 2015 Jun; 47(6):452-5. PubMed ID: 25354328
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M
Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511
[TBL] [Abstract][Full Text] [Related]
6. Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.
Simbolo M; Vicentini C; Mafficini A; Fassan M; Pedron S; Corbo V; Mastracci L; Rusev B; Pedrazzani C; Landoni L; Grillo F; Cingarlini S; Rindi G; Luchini C; Scarpa A; Lawlor RT
Virchows Arch; 2018 Dec; 473(6):709-717. PubMed ID: 30219970
[TBL] [Abstract][Full Text] [Related]
7. Genetics and epigenetics in small intestinal neuroendocrine tumours.
Stålberg P; Westin G; Thirlwell C
J Intern Med; 2016 Dec; 280(6):584-594. PubMed ID: 27306880
[TBL] [Abstract][Full Text] [Related]
8. CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
Viotto D; Russo F; Anania I; Segatto I; Rampioni Vinciguerra GL; Dall'Acqua A; Bomben R; Perin T; Cusan M; Schiappacassi M; Gerratana L; D'Andrea S; Citron F; Vit F; Musco L; Mattevi MC; Mungo G; Nicoloso MS; Sonego M; Massarut S; Sorio R; Barzan L; Franchin G; Giorda G; Lucia E; Sulfaro S; Giacomarra V; Polesel J; Toffolutti F; Canzonieri V; Puglisi F; Gattei V; Vecchione A; Belletti B; Baldassarre G
J Pathol; 2021 Feb; 253(2):234-245. PubMed ID: 33140857
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic targets.
Andersson E; Arvidsson Y; Swärd C; Hofving T; Wängberg B; Kristiansson E; Nilsson O
Mod Pathol; 2016 Jun; 29(6):616-29. PubMed ID: 26965582
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 18 Loss of Heterozygosity in Small Intestinal Neuroendocrine Tumours: Multi-Omic and Tumour Composition Analyses.
Waterfield S; Yousefi P; Webster A; Relton C; Thirlwell C; Suderman M
Neuroendocrinology; 2023; 113(9):915-923. PubMed ID: 36907174
[TBL] [Abstract][Full Text] [Related]
11. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours.
Scarpa A
Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: Clinical course and genetic profiling.
Norlén O; Edfeldt K; Akerstrom G; Westin G; Hellman P; Bjorklund P; Stalberg P
Surgery; 2014 Dec; 156(6):1512-21; discussion 1521-2. PubMed ID: 25456945
[TBL] [Abstract][Full Text] [Related]
13. miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient survival.
Arvidsson Y; Rehammar A; Bergström A; Andersson E; Altiparmak G; Swärd C; Wängberg B; Kristiansson E; Nilsson O
Mod Pathol; 2018 Aug; 31(8):1302-1317. PubMed ID: 29487354
[TBL] [Abstract][Full Text] [Related]
14. Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.
Fotouhi O; Adel Fahmideh M; Kjellman M; Sulaiman L; Höög A; Zedenius J; Hashemi J; Larsson C
Epigenetics; 2014 Jul; 9(7):987-97. PubMed ID: 24762809
[TBL] [Abstract][Full Text] [Related]
15. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
[TBL] [Abstract][Full Text] [Related]
16. IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence.
Massironi S; Del Gobbo A; Cavalcoli F; Fiori S; Conte D; Pellegrinelli A; Milione M; Ferrero S
Endocrine; 2017 Nov; 58(2):360-367. PubMed ID: 28210937
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors.
How-Kit A; Dejeux E; Dousset B; Renault V; Baudry M; Terris B; Tost J
Epigenomics; 2015; 7(8):1245-58. PubMed ID: 26360914
[TBL] [Abstract][Full Text] [Related]
18. Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors.
Walter D; Harter PN; Battke F; Winkelmann R; Schneider M; Holzer K; Koch C; Bojunga J; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Waidmann O
Sci Rep; 2018 Feb; 8(1):3811. PubMed ID: 29491456
[TBL] [Abstract][Full Text] [Related]
19. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
Karlsson A; Jönsson M; Lauss M; Brunnström H; Jönsson P; Borg Å; Jönsson G; Ringnér M; Planck M; Staaf J
Clin Cancer Res; 2014 Dec; 20(23):6127-40. PubMed ID: 25278450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
